CRP and coronary artery disorder: Figure 1 categorizes our study population according to the 2003 Joint American Heart Association and Center for Disease Control and Prevention (AHA-CDC) (Ref) guidelines for risk stratification of CAD based on CRP titres as follows: low risk <1 mg/L, moderate risk 1–3 mg/L, and high risk >3 mg/L.